Taken together, our findings suggested that genetic variant of rs3740194 in CELF2 gene might be a valuable predictor for NPC prognosis, and potentially useful in the personalized treatment of NPC. The gene discussed is CELF2; the disease is nasopharyngeal carcinoma.